GB0713192D0 - Anti-tumour methods - Google Patents
Anti-tumour methodsInfo
- Publication number
- GB0713192D0 GB0713192D0 GBGB0713192.3A GB0713192A GB0713192D0 GB 0713192 D0 GB0713192 D0 GB 0713192D0 GB 0713192 A GB0713192 A GB 0713192A GB 0713192 D0 GB0713192 D0 GB 0713192D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- tumour
- methods
- tumour methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0713192.3A GB0713192D0 (en) | 2007-07-06 | 2007-07-06 | Anti-tumour methods |
PCT/GB2008/002224 WO2009007677A2 (en) | 2007-07-06 | 2008-06-27 | Anti-tumour methods |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0713192.3A GB0713192D0 (en) | 2007-07-06 | 2007-07-06 | Anti-tumour methods |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0713192D0 true GB0713192D0 (en) | 2007-08-15 |
Family
ID=38440558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0713192.3A Ceased GB0713192D0 (en) | 2007-07-06 | 2007-07-06 | Anti-tumour methods |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0713192D0 (en) |
WO (1) | WO2009007677A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9040551B2 (en) | 2009-06-04 | 2015-05-26 | The Governors Of The University Of Alberta | Small molecule inhibitors of polynucleotide kinase/phosphatase, poly(ADP-ribose) polymerase and uses thereof |
US20140248293A1 (en) | 2011-09-08 | 2014-09-04 | Yeda Research And Development Co., Ltd | Novel risk biomarkers for lung cancer |
CN106995840B (en) * | 2017-03-20 | 2020-05-05 | 山东师范大学 | Method for detecting activity of thymine DNA glycosylase based on double-signal amplification strategy mediated by cyclic enzyme repair |
CN110408694A (en) * | 2018-04-26 | 2019-11-05 | 胤安国际(辽宁)基因科技股份有限公司 | Temozolomide is assessed in the new method of the sensibility for the treatment of Patients with gliomas |
CN109321658B (en) * | 2018-11-23 | 2021-09-07 | 浙江大学 | Kit for detecting susceptibility of cervical cancer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090062196A1 (en) * | 2006-10-20 | 2009-03-05 | D Andrea Alan | Compositions and methods of treating cancer |
-
2007
- 2007-07-06 GB GBGB0713192.3A patent/GB0713192D0/en not_active Ceased
-
2008
- 2008-06-27 WO PCT/GB2008/002224 patent/WO2009007677A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009007677A3 (en) | 2009-11-26 |
WO2009007677A2 (en) | 2009-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0706709D0 (en) | Methods | |
AP2010005314A0 (en) | Nanodispersian | |
HK1132673A1 (en) | Novel methods | |
GB0718160D0 (en) | Methods | |
GB0713192D0 (en) | Anti-tumour methods | |
EP2161998A4 (en) | Novel methods | |
GB0715502D0 (en) | Methods | |
GB0714842D0 (en) | Methods | |
GB0707735D0 (en) | Methods | |
GB0722113D0 (en) | Easiboss | |
GB0719252D0 (en) | Methods | |
GB0713673D0 (en) | Methods | |
GB0806623D0 (en) | My leener | |
GB0724222D0 (en) | Methods | |
GB0722035D0 (en) | Methods | |
GB0715542D0 (en) | Methods | |
GB0714265D0 (en) | Methods | |
GB0713281D0 (en) | Methods | |
GB0712401D0 (en) | Methods | |
GB0700966D0 (en) | Methods | |
GB0701417D0 (en) | Methods | |
GB0724281D0 (en) | Combinations | |
GB0716863D0 (en) | Prambrolly | |
GB0722634D0 (en) | Mariemaid | |
GB0714089D0 (en) | Spherikill |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |